ArticleEquity neuroscience2025
Locally adapting digital health technologies to address the global challenge of Parkinson's disease.
Article in Equity neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The Hidden Burden of Parkinson's Disease in Cambodia: A Call to Action.Public health challenges · 2026Article
- Clinical characteristics and predictors of disease progression in parkinson's disease in a cohort of patients in the ashanti region, Ghana.Equity neuroscience · 2026Article
- Bridging the global Parkinson's divide: Technology as a structural solution for equitable and brain health-integrated care.Journal of Parkinson's disease · 2026Review
- Clinical characteristics of Parkinson's disease in the outpatient clinic of a regional hospital in Peru.Revista peruana de medicina experimental y salud publica · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Parkinson's disease is the fastest growing neurological disorder worldwide. As the global burden of the disease continues to grow, along with the environmental consequences of industrialization, it remains essential to diagnose, treat, and study Parkinson's disease among historically marginalized populations living in remote and relatively unindustrialized regions of the world. The diagnosis and monitoring of the motor manifestations of the disease depends on in-person examination of the speed, amplitude, and frequency of movement by trained providers. Digital health technologies allow synchronous, remote, video-based access to trained providers able to diagnose and monitor the progression of Parkinson's disease using clinical rating scales. Digital health technologies can be expensive, and their use requires sustainable access to trained providers, powerful computers and high-speed internet that are not widely available for historically marginalized populations, such as those living in remote Andean regions of Latin America. Local adaptation of health technologies could be promoted in partnership with historically marginalized communities to study their unique epidemiology while building local capacity to expand care and support community-driven education and research efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.